Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases

Jean François Korobelnik; Paolo Lanzetta; Charles C. Wykoff; Tien Y. Wong; Xin Zhang; Peter Morgan-Warren; Scott Fitzpatrick; Sergio Leal; Lynne Brunck; Zoran Hasanbasic; Karen W. Chu; Kimberly Reed; Sobha Sivaprasad

doi:10.1038/s41433-024-03312-w

Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases

Jean François Korobelnik, Paolo Lanzetta, Charles C. Wykoff, Tien Y. Wong, Xin Zhang, Peter Morgan-Warren, Scott Fitzpatrick, Sergio Leal, Lynne Brunck, Zoran Hasanbasic, Karen W. Chu, Kimberly Reed, Sobha Sivaprasad

Research output: Contribution to journal › Comment/debate › peer-review

13 Scopus citations

Original language	English (US)
Pages (from-to)	3218-3221
Number of pages	4
Journal	Eye (Basingstoke)
Volume	38
Issue number	17
DOIs	https://doi.org/10.1038/s41433-024-03312-w
State	Published - Dec 2024

ASJC Scopus subject areas

Ophthalmology
Sensory Systems

Access to Document

10.1038/s41433-024-03312-w

Cite this

Korobelnik, J. F., Lanzetta, P., Wykoff, C. C., Wong, T. Y., Zhang, X., Morgan-Warren, P., Fitzpatrick, S., Leal, S., Brunck, L., Hasanbasic, Z., Chu, K. W., Reed, K., & Sivaprasad, S. (2024). Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases. Eye (Basingstoke), 38(17), 3218-3221. https://doi.org/10.1038/s41433-024-03312-w

Korobelnik, JF, Lanzetta, P, Wykoff, CC, Wong, TY, Zhang, X, Morgan-Warren, P, Fitzpatrick, S, Leal, S, Brunck, L, Hasanbasic, Z, Chu, KW, Reed, K & Sivaprasad, S 2024, 'Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases', Eye (Basingstoke), vol. 38, no. 17, pp. 3218-3221. https://doi.org/10.1038/s41433-024-03312-w

@article{c18f0d2c352c4b10a2c7cc1939049225,

title = "Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases",

author = "Korobelnik, \{Jean Fran{\c c}ois\} and Paolo Lanzetta and Wykoff, \{Charles C.\} and Wong, \{Tien Y.\} and Xin Zhang and Peter Morgan-Warren and Scott Fitzpatrick and Sergio Leal and Lynne Brunck and Zoran Hasanbasic and Chu, \{Karen W.\} and Kimberly Reed and Sobha Sivaprasad",

year = "2024",

month = dec,

doi = "10.1038/s41433-024-03312-w",

language = "English (US)",

volume = "38",

pages = "3218--3221",

journal = "Eye (Basingstoke)",

issn = "0950-222X",

publisher = "Springer Nature",

number = "17",

}

TY - JOUR

T1 - Sustained disease control with aflibercept 8 mg

T2 - a new benchmark in the management of retinal neovascular diseases

AU - Korobelnik, Jean François

AU - Lanzetta, Paolo

AU - Wykoff, Charles C.

AU - Wong, Tien Y.

AU - Zhang, Xin

AU - Morgan-Warren, Peter

AU - Fitzpatrick, Scott

AU - Leal, Sergio

AU - Brunck, Lynne

AU - Hasanbasic, Zoran

AU - Chu, Karen W.

AU - Reed, Kimberly

AU - Sivaprasad, Sobha

PY - 2024/12

Y1 - 2024/12

UR - https://www.scopus.com/pages/publications/85202842398

UR - https://www.scopus.com/inward/citedby.url?scp=85202842398&partnerID=8YFLogxK

U2 - 10.1038/s41433-024-03312-w

DO - 10.1038/s41433-024-03312-w

M3 - Comment/debate

C2 - 39217260

AN - SCOPUS:85202842398

SN - 0950-222X

VL - 38

SP - 3218

EP - 3221

JO - Eye (Basingstoke)

JF - Eye (Basingstoke)

IS - 17

ER -

Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this